跳至主要内容
临床试验/NL-OMON21395
NL-OMON21395暂停不适用

Catheter ablation versus Amiodarone to pRevent Future ventricular tachycardia Episodes in patients with a defibrillator and a history of a myocardial infarction.

Isala Klinieken, Locatie Weezenlanden, Department of Cardiology0 个研究点目标入组 116 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
116

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Prior myocardial infarction, at least 3 months ago;
  • 2. ICD implantation for any cause except for: Brugada syndrome, ARVC, HCM, LQTS, SQTS, cathecholaminergic polymorphic VT, other channelopathies;

排除标准

  • 1. Age < 18 years;
  • 2. Use of amiodarone more than 7 days before randomization within the period of 3 months before randomization. If a patient used amiodarone in preceding 3 months, the plasma levels of amiodarone and desethylamiodarone will be determined. If both levels are > 1mg/L the patient will be excluded from the study;

研究者

发起方
Isala Klinieken, Locatie Weezenlanden, Department of Cardiology

相似试验